Lb Pharmaceuticals LBRX
NASDAQ LBRX
$37.95 -0.43 (-1.12%)
As of: Oct 1, 2026 · 1:50 PM EDT

Lb Pharmaceuticals (LBRX) Other Non-Current Liabilities (2024 - 2026)

Updated

Lb Pharmaceuticals' Other Non-Current Liabilities was $1.41 million in Q2 2026, up 23.2% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at Lb Pharmaceuticals came in at $1.34 million, down 46.4% from FY2024.

  • In earlier years, Other Non-Current Liabilities was $2.5 million in FY2024.
  • The Q2 2026 figure marks the highest quarterly Other Non-Current Liabilities since Q4 2024.
  • Per Business Quant data, LBRX's Other Non-Current Liabilities in the three quarters before Q2 2026 was $1.14 million (Q1 2026), $1.34 million (Q4 2025) and $942,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.41 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 1.34 Mn
Sep 30, 2025 942,000.00
Dec 31, 2024 2.50 Mn
API Access

Lb Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LBRX&period=max&api_key=YOUR_API_KEY